At Pfizer, we discover and develop novel vaccines that help protect people around the world from deadly viruses and bacteria. In 2018, we focused on rational vaccine design — understanding the structure of proteins enabled by high-tech tools like cryo-electron microscopy as a basis to design and produce those proteins for use in vaccines.
July 2, 2019 /3BL Media/ Today Pfizer Australia hosts a gathering of 40 of its non-traditional industry partners to discuss volunteerism and potential collaborative efforts with the United Nations, corporations, nonprofits, academia, and other stakeholders to address Australia’s needs as part of the
Corporate Social Responsibility Software Leader Recognizes Clients Patagonia, Pfizer, and Wells Fargo
Press Release
NASHVILLE, Tenn., July 1, 2019 /3BL Media/ - CyberGrants, the leading provider of corporate social responsibility software, today announced the winners of the Ovation Awards at their annual Social Impact Leadership Conference in Nashville. Recognizing organizations for their contributions and deep commitment to philanthropic excellence, vision, and inspirational social impact, the company is honored to announce this years’ recipients: Patagonia, Pfizer compassionate access program PfizerCAReS, and Wells Fargo.
Pfizer is committed to ensuring that the manufacturing, use and disposal of our products, including antibiotics, does not adversely affect human health or the environment. Core to this commitment is taking action to assess and reduce, as needed, the risk of antibiotics in wastewater from Pfizer and supplier manufacturing facilities
Our approach to global health challenges unleashes the full power of our resources to help strengthen healthcare systems and increase access for the most vulnerable people around the world. Pfizer’s commitment to skills-based volunteering deploys one of our greatest assets, our colleagues, to help NGOs around the world to address pressing health issues in resource-challenged settings. The Global Health Fellows (GHF) and Global Health Teams (GHT) programs place Pfizer colleagues on skills-sharing assignments with key partner organizations to help strengthen local health systems.
We live in challenging, often contentious times, with political, cultural and environmental issues constantly brewing. Companies across industries face the daunting task of appropriately responding to issues and news on a regular basis, and to help guide our responses at Pfizer, we developed our Social Framework – a way to determine if, when, how and why we will address a societal issue.
We are experiencing an exciting new era in drug discovery and development with scientific advances that could result in future breakthroughs. To make this promise a reality, Pfizer is dedicated to investing in manufacturing capabilities to keep pace with science today, and to plan for what’s coming next.
Today, Pfizer released the 2018 Annual Review highlighting the ways that patients are the driving force behind every aspect of the company’s business in its mission to deliver innovative medicines and vaccines that help improve health and well-being at every stage of life.
This year, the integrated report explores how Pfizer’s work keeps Patients at Our Center. Highlights include:
At Pfizer, we believe that empowered women help build stronger communities. Fundamental to this belief is ensuring access to resources that allow women to make decisions about the health of themselves and their families.
In 2018, Pfizer celebrated 15 years of the Global Health Fellows (GHF) program, our signature international corporate volunteer initiative that places colleagues on short-term assignments with international development organizations to help improve healthcare systems and build local healthcare capacity in underserved communities. For program partners, it brings much-needed resources, specific technical skills and a fresh mindset.
